摘要
科学界正在努力了解杂环和稠杂环的在药物发现计划作用,缘于他们对抗癌药物多药耐药(MDR)的影响。为许多年来各种支架的架构在肿瘤治疗已成逐渐增加。到目前为止还没有一种非常熟练可以从根部治愈癌症的治疗方法.。因此,设计具有最小副作用的新型抗癌药物是十分必要的.。从天然引线合成杂化物是药物化学的基本原理之一.。发明新的有效药物战胜癌症仍然是一大挑战。融合分子作为抗癌剂的设计与合成是当今时代的重大创新之一.。在药物发现中的原型,各种杂环化合物被认为是新的引领化合物的发展。本文提出了一些最新全世界此领域中的抗癌杂环药物进展,也使各种人类肿瘤细胞株IC50值最有前途的分子结构的构效关系受关注。
关键词: 含氮杂环,细胞毒性药物,融合,天然引物,IC50,恶二唑类。
Current Medicinal Chemistry
Title:A Comprehensive Review of N-Heterocycles as Cytotoxic Agents
Volume: 23 Issue: 38
Author(s): Dinesh Kumar and Subheet Kumar Jain
Affiliation:
关键词: 含氮杂环,细胞毒性药物,融合,天然引物,IC50,恶二唑类。
摘要: Scientific community is striving to understand the role of heterocycles and fused heterocycles in drug discovery programme due to its impact on multi-drug resistance (MDR) of anticancer drugs. Architecting of various scaffolds for cancer treatment has become gradually increased in many years. Till now there is no treatment which is so proficient that it can cure the cancer from the roots. Hence, it is very necessary to design novel anticancer agents with minimum side effects. Synthesis of hybrids from natural leads is one of the rationale approaches in medicinal chemistry. It remains a big challenge to invent new efficient drugs to beat cancer. The design and synthesis of fused molecules as anticancer agents is one of the great innovations of modern era. In drug discovery archetype, a variety of heterocycles have been considered for the development of novel lead compounds. This article presents some recent advancements in the field of anticancer heterocyclic agents all around the world and also attracted the structure activity relationship along with the structure of the most promising molecules along with IC50 values against various human cancer cell lines.
Export Options
About this article
Cite this article as:
Dinesh Kumar and Subheet Kumar Jain , A Comprehensive Review of N-Heterocycles as Cytotoxic Agents, Current Medicinal Chemistry 2016; 23 (38) . https://dx.doi.org/10.2174/0929867323666160809093930
DOI https://dx.doi.org/10.2174/0929867323666160809093930 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements